-
CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB
04 Aug 2025 22:50 GMT
… 04, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ … forward-looking statements. Contact Cyclacel Pharmaceuticals, Inc.
Email: IR@ … are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE:
Cyclacel Pharmaceuticals, Inc. 1 Yoojin …
-
CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY
16 Jul 2025 13:00 GMT
… to Cyclacel Pharmaceuticals, Inc., at ir@cyclacel.com. Contacts Cyclacel Pharmaceuticals, … cyclacel.com © Copyright 2025 Cyclacel Pharmaceuticals, Inc. All Rights Reserved … trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE:
Cyclacel Pharmaceuticals, Inc.
-
Why Is Cyclacel Pharmaceuticals Stock Soaring On Tuesday?
16 Jul 2025 01:47 GMT
Cyclacel Pharmaceuticals, Inc. CYCC stock is trading …
-
CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT
07 Jul 2025 10:00 GMT
… to Cyclacel Pharmaceuticals, Inc., at ir@cyclacel.com. Contacts Cyclacel Pharmaceuticals, … cyclacel.com © Copyright 2025 Cyclacel Pharmaceuticals, Inc. All Rights Reserved … trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE:
Cyclacel Pharmaceuticals, Inc.
-
CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER
07 Jul 2025 10:00 GMT
… forward-looking statements. Contact Cyclacel Pharmaceuticals, Inc.
Email: IR@ … cyclacel.com © Copyright 2025 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. … ® are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE:
Cyclacel Pharmaceuticals, Inc. 1 Chan …
-
Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock
20 Jun 2025 20:30 GMT
… 20, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (“Cyclacel”) (NASDAQ: CYCC, NASDAQ … legal counsel to Cyclacel. About Cyclacel Pharmaceuticals, Inc. Cyclacel is a clinical …
-
CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
03 Jun 2025 20:15 GMT
… For further information contact: Cyclacel Pharmaceuticals, Inc.
Datuk Dr. Doris … looking statements. © Copyright 2025 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. … are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE:
Cyclacel Pharmaceuticals, Inc.
-
CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
15 May 2025 04:50 GMT
… : doris@cyclacel.com © Copyright 2025 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The … Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE:
Cyclacel Pharmaceuticals, Inc. CYCLACEL PHARMACEUTICALS, INC.
CONSOLIDATED STATEMENTS …
-
CYCLACEL PHARMACEUTICALS ANNOUNCES STOCK SPLIT
07 May 2025 13:00 GMT
… future events or otherwise. Contacts Cyclacel Pharmaceuticals, Inc.
Datuk Dr. Doris … ir@cyclacel.com © Copyright 2025 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. … ® are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE:
Cyclacel Pharmaceuticals, Inc.
-
CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCHANGE AGREEMENT TO MAKE FITTERS SDN. BHD. ITS WHOLLY-OWNED SUBSIDIARY TO ACCELERATE GROWTH AND STOCKHOLDER VALUE
06 May 2025 10:00 GMT
… 06, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ … . For further information contact: Cyclacel Pharmaceuticals, Inc.
Datuk Dr. Doris … ® are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE:
Cyclacel Pharmaceuticals, Inc.
About
© 1995-2025